Skip to main content
RVTY
NYSE Life Sciences

Revvity to Acquire Human Cell Design, Bolstering Metabolic Disease Drug Discovery

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$126
Mkt Cap
$14.18B
52W Low
$81.22
52W High
$133
52W Position info
55% above low
Off High info
5.3% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

RVTY sits 55% above its 52-week low of $81.22.

Summary

Revvity is acquiring Human Cell Design, a specialist in human-relevant cell models for metabolic disease drug discovery. The deal strengthens Revvity's position in the high-growth metabolic disease research market, aligning with its life sciences strategy. No financial terms were disclosed, but the acquisition adds differentiated technology and likely complements existing offerings. This follows a strong Q2 where Revvity beat estimates and raised guidance, suggesting continued investment in growth areas. Watch for integration details and any impact on near-term earnings.

At the time of this announcement, RVTY was trading at $126.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $14.2B. The 52-week trading range was $81.22 to $133.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

RVTY - Latest Insights

RVTY
Nov 03, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $167.00
Real-time Price: $157.84 info
Change: -$9.16 (-5%) info
Market Cap: $17.613B info
RVTY
Nov 03, 2026, 6:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $157.77
Real-time Price: $157.84 info
Change: +$0.070 (+0.04%) info
Market Cap: $17.613B info
RVTY
Aug 11, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $115.73
Real-time Price: $157.84 info
Change: +$42.11 (+36%) info
Market Cap: $17.613B info
RVTY
Aug 04, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $115.00
Real-time Price: $157.84 info
Change: +$42.84 (+37%) info
Market Cap: $17.613B info
RVTY
Aug 04, 2026, 6:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $115.00
Real-time Price: $157.84 info
Change: +$42.84 (+37%) info
Market Cap: $17.613B info